{{Rsnum
|rsid=4074947
|Gene=AXIN2
|Chromosome=17
|position=65531102
|Orientation=minus
|GMAF=0.3021
|Gene_s=AXIN2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 57.5 | 35.4 | 7.1
| HCB | 31.4 | 55.5 | 13.1
| JPT | 31.9 | 46.9 | 21.2
| YRI | 38.8 | 44.9 | 16.3
| ASW | 50.9 | 42.1 | 7.0
| CHB | 31.4 | 55.5 | 13.1
| CHD | 32.1 | 52.3 | 15.6
| GIH | 54.5 | 37.6 | 7.9
| LWK | 47.3 | 45.5 | 7.3
| MEX | 43.1 | 55.2 | 1.7
| MKK | 46.8 | 41.7 | 11.5
| TSI | 53.9 | 39.2 | 6.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=24078348
|Title=An Analysis of Polymorphisms Within the Wnt Signaling Pathway in Relation to Ovarian Cancer Risk in a Polish Population
|OA=1
}}

{{PMID Auto
|PMID=18708403
|Title=Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}